Los Angeles Capital Management
SGMO

Los Angeles Capital Management’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Los Angeles Capital Management’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-19,083
Closed -$24.8K – 1224
2023
Q2 		$24.8K Buy
19,083
+3,412
+22% +$4.66K ﹤0.01% 1147
2023
Q1 		$27.6K Sell
15,671
-2,405
-13% -$6.86K ﹤0.01% 1149
2022
Q4 		$56.8K Sell
18,076
-90,267
-83% -$350K ﹤0.01% 1176
2022
Q3 		$531K Buy
108,343
+61,285
+130% +$315K ﹤0.01% 908
2022
Q2 		$195K Hold
47,058
– – ﹤0.01% 1271
2022
Q1 		$273K Hold
47,058
– – ﹤0.01% 1275
2021
Q4 		$353K Sell
47,058
-13,095
-22% -$114K ﹤0.01% 1173
2021
Q3 		$542K Hold
60,153
– – ﹤0.01% 1012
2021
Q2 		$720K Sell
60,153
-3,500
-5% -$39.6K ﹤0.01% 1004
2021
Q1 		$798K Sell
63,653
-103,320
-62% -$1.39M ﹤0.01% 1007
2020
Q4 		$2.61M Buy
166,973
+93,361
+127% +$1.09M 0.01% 576
2020
Q3 		$696K Buy
73,612
+29,120
+65% +$315K ﹤0.01% 952
2020
Q2 		$399K Buy
+44,492
New +$413K ﹤0.01% 1191
2018
Q4 		– Sell
-89,686
Closed -$1.52M – 1370
2018
Q3 		$1.52M Hold
89,686
– – 0.01% 743
2018
Q2 		$1.27M Buy
89,686
+43,000
+92% +$714K 0.01% 825
2018
Q1 		$887K Buy
46,686
+31,840
+214% +$681K 0.01% 865
2017
Q4 		$243K Buy
+14,846
New +$221K ﹤0.01% 1219
2015
Q2 		– Sell
-22,560
Closed -$354K – 1246
2015
Q1 		$354K Buy
+22,560
New +$349K ﹤0.01% 1014
2014
Q3 		– Sell
-14,610
Closed -$223K – 1153
2014
Q2 		$223K Buy
+14,610
New +$210K ﹤0.01% 1115

Other funds holding SGMO

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMU
Rokos Capital Management (UK) London, United Kingdom $13.2B AUM 85.71% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Los Angeles Capital Management's SGMO Position: Q3 2023 in Review

Los Angeles Capital Management sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q3 2023, closing a stake of 19,083 shares — an estimated $24.8K sold.

Los Angeles Capital Management first reported a position in SGMO in Q2 2014 and held it in 19 quarters. The position peaked at $2.61M in Q4 2020. 134 funds tracked by Wall St. Rank hold SGMO as of Q3 2023.

  • Los Angeles Capital Management reported no remaining SANGAMO THERAPEUTICS INC position as of Q3 2023 after selling out during the quarter.
  • Los Angeles Capital Management sold 19,083 SANGAMO THERAPEUTICS INC shares in Q3 2023, an estimated $24.8K.
  • Los Angeles Capital Management first reported a position in SANGAMO THERAPEUTICS INC in Q2 2014 and held it in 19 quarters.
  • Los Angeles Capital Management's SANGAMO THERAPEUTICS INC position peaked at $2.61M in Q4 2020.
  • 134 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q3 2023.

Based on Los Angeles Capital Management's 13F filing for Q3 2023, filed 6 Nov 2023.